Nonobstructive Hypertrophic Cardiomyopathy clinical trials

Explore recruiting nonobstructive hypertrophic cardiomyopathy clinical trials.

Recruiting nonobstructive hypertrophic cardiomyopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nonobstructive Hypertrophic Cardiomyopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

BMS CV027-031, A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Czechia, Belgium, Norway, Spain, Poland, Hungary +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Nonobstructive Hypertrophic Cardiomyopathy trials by city

Nonobstructive Hypertrophic Cardiomyopathy in Toronto Nonobstructive Hypertrophic Cardiomyopathy in Vancouver Nonobstructive Hypertrophic Cardiomyopathy in Montreal Nonobstructive Hypertrophic Cardiomyopathy in Calgary Nonobstructive Hypertrophic Cardiomyopathy in Edmonton Nonobstructive Hypertrophic Cardiomyopathy in Ottawa Nonobstructive Hypertrophic Cardiomyopathy in Winnipeg Nonobstructive Hypertrophic Cardiomyopathy in Quebec City Nonobstructive Hypertrophic Cardiomyopathy in Hamilton Nonobstructive Hypertrophic Cardiomyopathy in Kitchener Nonobstructive Hypertrophic Cardiomyopathy in London Nonobstructive Hypertrophic Cardiomyopathy in Halifax Nonobstructive Hypertrophic Cardiomyopathy in New York Nonobstructive Hypertrophic Cardiomyopathy in Los Angeles Nonobstructive Hypertrophic Cardiomyopathy in Chicago Nonobstructive Hypertrophic Cardiomyopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease